v3.26.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies [Abstract]  
Schedule of Milestone Payments that the Group is Required to Pay up to Different Achievements The aggregate amounts of the contingent milestone payments that the Group is required to pay up to different achievements of conditions and milestones under all license agreements in effect as of December 31, 2025 are below:
   Amount 
Drug molecules: up to the conditions and milestones of    
From entering phase 1 to before first commercial sale   920,000 
First commercial sale   800,000 
Net sales amount more than certain threshold in a year   7,000,000 
Subtotal  $8,720,000